Vandervoort Adam C 4
4 · Teladoc Health, Inc. · Filed Dec 3, 2025
Insider Transaction Report
Form 4
Vandervoort Adam C
CHIEF LEGAL OFFICER, SECRETARY
Transactions
- Exercise/Conversion
Common Stock
2025-12-01+1,505→ 76,684 total - Exercise/Conversion
Common Stock
2025-12-01+4,418→ 81,102 total - Exercise/Conversion
Common Stock
2025-12-01+5,350→ 86,452 total - Sale
Common Stock
2025-12-02$7.49/sh−5,720$42,831→ 80,732 total - Exercise/Conversion
Performance Stock Units
2025-12-01−1,505→ 1,510 total→ Common Stock (1,505 underlying) - Exercise/Conversion
Restricted Stock Units
2025-12-01−4,418→ 4,418 total→ Common Stock (4,418 underlying) - Exercise/Conversion
Restricted Stock Units
2025-12-01−5,350→ 26,750 total→ Common Stock (5,350 underlying)
Footnotes (7)
- [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
- [F4]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F5]On March 3, 2023, the reporting person was granted 53,013 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
- [F6]Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- [F7]One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.